Papers - YONEYAMA Tohru
-
Significance of preoperative butyrylcholinesterase as an independent predictor of biochemical recurrence-free survival in patients with prostate cancer treated with radical prostatectomy
Takuya Koie, Chikara Ohyama, Shingo Hatakeyama, Atsushi Imai, Takahiro Yoneyama, Yasuhiro Hashimoto, Tohru Yoneyama, Yuki Tobisawa, Shogo Hosogoe, Hayato Yamamoto, Masato Kitayama, Kazuyoshi Hirota
International Journal of Clinical Oncology 21 ( 2 ) 379 - 383 2016.4
-
I-branching N-acetylglucosaminyltransferase regulates prostate cancer invasiveness by enhancing α5β1 integrin signaling.
Mikami J, Tobisawa Y, Yoneyama T, Hatakeyama S, Mori K, Hashimoto Y, Koie T, Ohyama C, Fukuda M
Cancer science 107 ( 3 ) 359 - 368 2016.2
-
Implication of aortic calcification on persistent hypertension after laparoscopic adrenalectomy in patients with primary aldosteronism.
Naoki Fujita, Shingo Hatakeyama, Hayato Yamamoto, Yuki Tobisawa, Tohru Yoneyama, Takahiro Yoneyama, Yasuhiro Hashimoto, Takuya Koie, Takeshi Nigawara, Chikara Ohyama
International journal of urology : official journal of the Japanese Urological Association 2016.2
-
Renal Function Outcomes and Risk Factors for Risk Factors for Stage 3B Chronic Kidney Disease after Urinary Diversion in Patients with Muscle Invasive Bladder Cancer
Shingo Hatakeyama, Takuya Koie, Takuma Narita, Shogo Hosogoe, Hayato Yamamoto, Yuki Tobisawa, Tohru Yoneyama, Takahiro Yoneyama, Yasuhiro Hashimoto, Chikara Ohyama
PLOS ONE 11 ( 2 ) e0149544 2016.2
-
Core 2 β-1, 6-N-acetylglucosaminyltransferase-1 expression in prostate biopsy specimen is an indicator of prostate cancer aggressiveness.
Tendo Sato, Tohru Yoneyama, Yuki Tobisawa, Shingo Hatakeyama, Hayato Yamamoto, Yuta Kojima, Jotaro Mikami, Kazuyuki Mori, Yasuhiro Hashimoto, Takuya Koie, Chikara Ohyama
Biochemical and biophysical research communications 470 ( 1 ) 150 - 156 2016.1
-
Core 2 (beta-1, 6-N-acetylglucosaminyltransferase-1 expression in prostate biopsy specimen is an indicator of prostate cancer aggressiveness
Tendo Sato, Tohru Yoneyama, Yuki Tobisawa, Shingo Hatakeyama, Hayato Yamamoto, Yuta Kojima, Jotaro Mikami, Kazuyuki Mori, Yasuhiro Hashimoto, Takuya Koie, Chikara Ohyama
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS 470 ( 1 ) 150 - 156 2016.1
-
Safety of heparin bridging therapy for transrectal ultrasound-guided prostate biopsy in patients requiring temporary discontinuation of antithrombotic agents.
Itsuto Hamano, Shingo Hatakeyama, Tohru Yoneyama, Yuki Tobisawa, Osamu Soma, Teppei Matsumoto, Hayato Yamamoto, Atsushi Imai, Takahiro Yoneyama, Yasuhiro Hashimoto, Takuya Koie, Chikara Ohyama
SpringerPlus 5 ( 1 ) 1917 - 1917 2016
-
The potential role of blood group antigen-targeting peptide in ABO-incompatible in renal transplantation
69 ( 13 ) 1093 - 1100 2015.12
-
I-branching N-acetylglucosaminyltransferase regulates prostate cancer invasiveness by enhancing α5β1 integrin signaling.
Jotaro Mikami, Yuki Tobisawa, Tohru Yoneyama, Shingo Hatakeyama, Kazuyuki Mori, Yasuhiro Hashimoto, Takuya Koie, Chikara Ohyama, Minoru Fukuda
Cancer science 2015.12
-
Neoadjuvant luteinizing-hormone-releasing hormone agonist plus low-dose estramustine phosphate improves prostate-specific antigen-free survival in high-risk prostate cancer patients: a propensity score-matched analysis
Takuya Koie, Koji Mitsuzuka, Takahiro Yoneyama, Shintaro Narita, Sadafumi Kawamura, Yasuhiro Kaiho, Norihiko Tsuchiya, Tatsuo Tochigi, Tomonori Habuchi, Yoichi Arai, Chikara Ohyama, Tohru Yoneyama, Yuki Tobisawa
INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY 20 ( 5 ) 1018 - 1025 2015.10
-
Detection of Core2 β-1,6-N-Acetylglucosaminyltransferase in Post-Digital Rectal Examination Urine Is a Reliable Indicator for Extracapsular Extension of Prostate Cancer.
Yuta Kojima, Tohru Yoneyama, Shingo Hatakeyama, Jotaro Mikami, Tendo Sato, Kazuyuki Mori, Yasuhiro Hashimoto, Takuya Koie, Chikara Ohyama, Minoru Fukuda, Yuki Tobisawa
PloS one 10 ( 9 ) e0138520 - e0138520 2015.9
-
Oncological outcomes of a single but extensive transurethral resection followed by appropriate intra-vesical instillation therapy for newly diagnosed non-muscle-invasive bladder cancer.
Takuya Koie, Chikara Ohyama, Shogo Hosogoe, Hayato Yamamoto, Atsushi Imai, Shingo Hatakeyama, Takahiro Yoneyama, Yasuhiro Hashimoto, Tohru Yoneyama, Yuki Tobisawa, Kazuyuki Mori
International urology and nephrology 47 ( 9 ) 1509 - 1514 2015.9
-
Detection of Core2 beta-1,6-N-Acetylglucosaminyltransferase in Post-Digital Rectal Examination Urine Is a Reliable Indicator for Extracapsular Extension of Prostate Cancer
Yuta Kojima, Tohru Yoneyama, Shingo Hatakeyama, Jotaro Mikami, Tendo Sato, Kazuyuki Mori, Yasuhiro Hashimoto, Takuya Koie, Chikara Ohyama, Minoru Fukuda, Yuki Tobisawa
PLOS ONE 10 ( 9 ) e0138520 2015.9
-
Oncological outcomes of a single but extensive transurethral resection followed by appropriate intra-vesical instillation therapy for newly diagnosed non-muscle-invasive bladder cancer
Takuya Koie, Chikara Ohyama, Shogo Hosogoe, Hayato Yamamoto, Atsushi Imai, Shingo Hatakeyama, Takahiro Yoneyama, Yasuhiro Hashimoto, Tohru Yoneyama, Yuki Tobisawa, Kazuyuki Mori
INTERNATIONAL UROLOGY AND NEPHROLOGY 47 ( 9 ) 1509 - 1514 2015.9
-
Significance of preoperative butyrylcholinesterase as an independent predictor of biochemical recurrence-free survival in patients with prostate cancer treated with radical prostatectomy.
Takuya Koie, Chikara Ohyama, Shingo Hatakeyama, Atsushi Imai, Takahiro Yoneyama, Yasuhiro Hashimoto, Tohru Yoneyama, Yuki Tobisawa, Shogo Hosogoe, Hayato Yamamoto, Masato Kitayama, Kazuyoshi Hirota
International journal of clinical oncology 2015.7
-
Carboplatin-based combination chemotherapy for elderly patients with advanced bladder cancer
Takahiro Yoneyama, Yuki Tobisawa, Tohru Yoneyama, Hayato Yamamoto, Atsushi Imai, Shingo Hatakeyama, Yasuhiro Hashimoto, Takuya Koie, Chikara Ohyama
INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY 20 ( 2 ) 369 - 374 2015.4
-
Feasibly of axitinib as first-line therapy for advanced or metastatic renal cell carcinoma: a single-institution experience in Japan
Takuya Koie, Chikara Ohyama, Takahiro Yoneyama, Hayato Yamamoto, Atsushi Imai, Shingo Hatakeyama, Yasuhiro Hashimoto, Tohru Yoneyama, Yuki Tobisawa, Kazuyuki Mori
BMC Urology 15 32 2015.4
-
Neoadjuvant luteinizing-hormone-releasing hormone agonist plus low-dose estramustine phosphate improves prostate-specific antigen-free survival in high-risk prostate cancer patients: a propensity score-matched analysis.
Takuya Koie, Koji Mitsuzuka, Takahiro Yoneyama, Shintaro Narita, Sadafumi Kawamura, Yasuhiro Kaiho, Norihiko Tsuchiya, Tatsuo Tochigi, Tomonori Habuchi, Yoichi Arai, Chikara Ohyama, Tohru Yoneyama, Yuki Tobisawa
International journal of clinical oncology 2015.2
-
Prostate-specific antigen density predicts extracapsular extension and increased risk of biochemical recurrence in patients with high-risk prostate cancer who underwent radical prostatectomy
Takuya Koie, Koji Mitsuzuka, Takahiro Yoneyama, Shintaro Narita, Sadafumi Kawamura, Yasuhiro Kaiho, Norihiko Tsuchiya, Tatsuo Tochigi, Tomonori Habuchi, Yoichi Arai, Chikara Ohyama, Tohru Yoneyama, Yuki Tobisawa
INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY 20 ( 1 ) 176 - 181 2015.2
-
Quantification of Prostate Cancer-Associated Aberrant Glycosylation of Prostate-Specific Antigen
Chikara Ohyama, Takuya Koie, Tohru Yoneyama, Yuki Tobisawa
Glycoscience: Biology and Medicine 1373 - 1377 2015.1